Influenza-related deaths - Available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe

Eurosurveillance

Volumn 17, Issue 18, 2012, Pages

  Nicoll, A ^a   Ciancio, B C ^a   Lopez Chavarrias, V ^a   Molbak K ^b   Pebody, R ^c   Pedzinski, B ^d   Penttinen, P ^a   van der Sande, M ^e,f   Snacken, R ^a   van Kerkhove, M D ^g  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; DEATH CERTIFICATE; DISEASE SURVEILLANCE; EUROPE; HEALTH PROGRAM; HUMAN; INFLUENZA; LABORATORY DIAGNOSIS; MORTALITY; PANDEMIC INFLUENZA; PNEUMONIA; PREMATURE MORTALITY; REGISTRATION; REVIEW; RISK FACTOR; SEASONAL INFLUENZA; STATISTICAL ANALYSIS;

EID: 84862879731     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.18.20162-en     Document Type: Review

References (103)

1. Monto AS, Comanor L, Shay DK, Thompson WW. Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. J Infectious Dis. 2006;194 Suppl 2:S92-S97.
2. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infectious Dis. 2006;12(1):9-14.
3. Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo JB. Public health and medical responses to the 1957-58 influenza pandemic. Biosecur Bioterror. 2009;7(3):265-273.
4. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L. Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr. 2010:RRN1153.
5. Viboud C, Boelle PY, Pakdaman K, Carrat F, Valleron AJ, Flahault A. Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerg Infect Dis. 2004;10(1):32-39.
6. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53-60.
7. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnager J, et al. 2009 Pandemic influenza A(H1N1) Pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177(1):166-175.
8. European Centre for Disease Prevention and Control (ECDC). The 2009 A(H1N1) pandemic in Europe - A review of the experience. Stockholm: ECDC; 2010. Available from: http://www.ecdc.europa.eu/en/publications/Publications/101108_SPR_pandemic_experience.pdf.
9. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944-1950.
10. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33):1057-1062. MMWR Morb Mortal Wkly Rep.
11. Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. Md State Med J. 1962;11:104-110.
12. Sprenger MJ, Van Naelten MA, Mulder PG, Masurel N. Influenza mortality and excess deaths in the elderly, 1967-82. Epidemiol Infect. 1989;103(3):633-641.
13. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. English mortality from A/H1N1. Comparisons with recent flu mortality. BMJ. 2010;340:c612.
14. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, Fraser C, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ. 2009;339:b2840.
15. Rizzo C, Bella A, Viboud C, Simonsen L, Miller MA, Rota MC, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis. 2007;13(5):694-699.
16. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002 Spring;76(1):105-115.
17. Dauer CC. Mortality in the 1957-58 influenza epidemic. Public Health Rep. 1958;73(9):803-810.
18. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1981;113(1):30-43.
19. Ansart S, Pelat C, Boelle PY, Carrat F, Flahault A, Valleron AJ. Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respi Viruses. 2009;3(3):99-106.
20. Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet. 2006;368(9554):2211-2218.
21. Thompson WW, Moore MR, Weintraub E, Cheng PY, Jin X, Bridges CB, et al. Estimating influenza-associated deaths in the United States. Am J Public Health. 2009,99 Suppl 2:S225-230.
22. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 15(20):pii=19571. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19571
23. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2009;84(46):481-484.
24. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010;51(10):1184-1191.
25. van den Wijngaard CC, van Asten L, Meijer A, van Pelt W, Nagelkerke NJ, Donker GA, et al. Detection of excess influenza severity: associating respiratory hospitalization and mortality data with reports of influenza-like illness by primary care physicians. Am J Public Health. 2010;100(11):2248-2254.
26. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324(5934):1557-1561.
27. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. Geneva: WHO; Feb 2011. Available from: http://www.who.int/entity/influenza/vaccines/2011_02_recommendation.pdf
28. Farr W. Tenth annual report of Registrar-General xii 1847. London: H.M. Stationery Office; 1847.
29. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis. 2009;15(12):2004-2007.
30. Collins SD. Influenza-pneumonia mortality in a group of about 95 cities in the United States, 1920-29. Pub Health Rep. 1930;45:361-406.
31. Centers for Diseaase Prevention and Control (CDC). Overview of Influenza Surveillance in the United States. Atlanta: CDC; 2 Oct 2011. Available from: http://www.cdc.gov/flu/weekly/pdf/verview.pdf
32. Choi K, Thacker SB. Mortality during influenza epidemics in the United States, 1967-1978. Am J Public Health. 1982;72(11):1280-1283.
33. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186.
34. Swine Flu UK. Planning Assumptions. London: Department of Health; 3 Sep 2009. Available from: http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_104843.pdf
35. Tillett HE, Smith JW, Clifford RE. Excess morbidity and mortality associated with influenza in England and Wales. Lancet. 1980;1(8172):793-795.
36. Wielders CC, van Lier EA, van't Klooster TM, van Gageldonk-Lafeber AB, van den Wijngaard CC, Haagsma JA, et al. The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health. 2012;22(1):150-157.
37. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep. 1963;78(6):494-506.
38. Barker WH, Mullooly JP. Underestimation of the role of pneumonia and influenza in causing excess mortality Am J Public Health. 1981;71(6):643-645.
39. Kyncl J, Prochazka B, Goddard NL, Havlickova M, Castkova J, Otavova M, et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Eur J Epidemiol. 2005;20(4):365-371.
40. Zucs P, Buchholz U, Haas W, Uphoff H. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol. 2005;2:6.
41. Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 1993;22(2):334-340.
42. Sprenger MJ, Mulder PG, Beyer WE, Masurel N. Influenza: relation of mortality to morbidity parameters--Netherlands, 1970-1989. Int J Epidemiol. 1991;20(4):1118-1124
43. Gran JM, Iversen B, Hungnes O, Aalen OO. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Epidemiol Infect. 2010;138(11):1559-1568.
44. Nogueira PJ, Nunes B, Machado A, Rodrigues E, Gomez V, Sousa L, et al. Early estimates of the excess mortality associated with the 2008-9 influenza season in Portugal. Euro Surveill. 2009 May 7;14(18):pii=19194. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19194
45. Egger MJ, S. Spuhler, T. Zimmremann, H.P. Paccaud, F. Somaini, B. [Mortality in influenza epidemics in Switzerland 1969-1985].Schweiz Med Wochenschr. 1989;119(13-14):434-439. [German].
46. Health Protection Agency (HPA). Surveillance of influenza and other respiratory viruses in the UK: 2010-2011. London: HPA; May 2011. Available from: http://www.hpa.org.uk/Publications/InfectiousDiseases/Influenza/1105influenzareport/
47. Wong CM, Chan KP, Hedley AJ, Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39(11):1611-1617.
48. Eurostat. Statistics. Luxembourg: European Commission; [Accessed: November 2010] http://epp.eurostat.ec.europa.eu/portal/page/portal/statistics/search_database
49. UK National Statistics. Population. Newport: Office for National Statistics; [Accessed: November 2010]. Population http://www.statistics.gov.uk/hub/population/index.html
50. Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health. 2008;98(5):939-945.
51. Noymer A. Influenza analysis should include pneumonia. Am J Public Health. 2008;98(11):1927-1928.
52. McLean E, Murdoch H, Reynolds A, Begum F, Thomas D, Smyth B, et al. Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2008 to April 2009. Health Protection Report. 2009:3(39). Available from: http://www.hpa.org.uk/hpr/archives/Infections/2009/respiratory09.htm#supp09
53. Patel M, Dennis A, Flutter C, Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth. 2010;104(2):128-142.
54. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362(18):1708-1719.
55. World Health Organization (WHO). Comparing deaths from pandemic and seasonal influenza. Pandemic (H1N1) 2009 briefing note 20. Geneva: WHO; 22 Dec 2009. Available from: http://www.who.int/csr/disease/swineflu/notes/briefing_20091222/en/index.html
56. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-1340.
57. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58(38):1071-1074.
58. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis.2007;45(12):1568-1575.
59. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601-610.
60. Lim MB, Bermingham A, Edmunds J, Fragaszy J, Harvey G, Johnson A, et al. Flu Watch. Community burden of Influenza during three influenza seasons and the summer wave of the 2009 H1N1 pandemic in England - implications for interpretation of surveillance data. Options for the Control of Influenza VII Options Conference; 3-7 Sep 2010; Hong Kong, China. P-321.
61. Mølbak K, Widgren K, Jensen KS, Ethelberg S, Andersen PH, Christiansen AH, et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine. 2011;29 Suppl 2:B63-B69.
62. van Gageldonk-Lafeber AB, Riesmeijer RM, Friesema IHM, Meijer A, Isken LD, Timen A, et al. Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season. BMC Public Health. 2011;11:758.
63. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-1952.
64. Cox CM, Blanton L, Dhara R, Brammer L, Finelli L. 2009 Pandemic Influenza A (H1N1) Deaths among Children-United States, 2009-2010. Clin Infect Dis. 2011;52 Suppl 1:S69-S74.
65. Australian Paediatric Surveillance Unit (APSU). APSU Update. Westmead: APSU; Aug 2010. Available from: http://www.apsu.org.au/download.cfm?DownloadFile=C7472E49-EA8F-7A9B-6ACA495A88D7DF11
66. Barker WH, Mullooly JP. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA. 1980;244(22):2547-2549.
67. Choi K, Thacker SB. From the centers for disease control. Improved accuracy and specificity of forecasting deaths attributed to pneumonia and influenza. J Infect Dis. 1981;144(6):606-608.
68. Aho M, Lyytikainen O, Nyholm J, Kuitunen T, Ronkko E, Santanen R, et al. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison - a serological survey. Euro Surveill. 2010;15(45):pii=19709. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19709
69. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112(6):798-811.
70. Barker WH, Mullooly JP. "A study of excess mortality during influenza epidemics in the United States, 1968-1976". Am J Epidemiol. 1982;115(3):479-480.
71. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 1987;77(6):712-716.
72. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses. 2009;3(1):37-49.
73. Neuzil KM, Maynard C, Griffin MR, Heagerty P. Winter respiratory viruses and health care use: a populationbased study in the northwest United States. Clin Infect Dis. 2003;37(2):201-207.
74. Stroup DF, Thacker SB, Herndon JL. Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962-1983. Stat Med. 1988;7(10):1045-1059.
75. ECDC. Revised estimates of deaths associated with seasonal influenza in the US Stockholm: ECDC; 2010 [29/11/2010]; Available from: http://ecdc.europa.eu/en/activities/sciadvice/Lists/ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f% 2D77d4%2D4ad8%2Db6d6%2Dbf0f23083f30&ID=952&RootFolder=%2Fen%2Factivities%2Fsciadvice%2FLists%2FECDC%20 Reviews
76. Centers for Disease Control and Prevention (CDC). FluView. Weekly influenza surveillance report. Atlanta: CDC. Available from: http://www.cdc.gov/flu/weekly/
77. Mazick A, Gergonne B, Wuillaume F, Danis K, Vantarakis A, Uphoff H, et al. Higher all-cause mortality in children during autumn 2009 compared with the three previous years: pooled results from eight European countries. Euro Surveill.15(5):pii=19480. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19480
78. Hardelid P, Andrews N, Pebody R. Excess mortality monitoring in England and Wales during the influenza A(H1N1) 2009 pandemic. Epidemiol Infect. 2011;139(9):1431-1439.
79. Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet. 2010;376(9755):1846-1852.
80. Gardner JW, Sanborn JS. Years of potential life lost (YPLL)-- what does it measure? Epidemiology. 1990;1(4):322-329.
81. Pandemic flu. A national framework for responding to an influenza pandemic. London: Department of Health; 2007. Available from: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_080745.pdf
82. Abraham T. The price of poor pandemic communication. BMJ. 2010;340:c2952.
83. European Center for Disease Prevention and Control (ECDC). Revised pandemic 2009 planning assumptions for Europe. Stockholm: ECDC; 16 Sep 2009. Available from: http://www.google.se/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=0CDgQFjAB&url=http%3A%2F%2Fecdc.europa.eu%2Fen%2Factivities%2Fsciadvice%2FLists%2FECDC%2520Reviews%2FECDC_DispForm.aspx%3FList%3D512ff74f-77d4-4ad8-b6d6-bf0f23083f30%26ID%3D650%26MasterPage%3D1%26PDF%3Dtrue&ei=nCiNT72bHMqQ4gSX4ITbDw&usg=AFQjCNFDbPJANxq6xA_xQm5ruyDYbSpQRw.
84. European Center for Disease Prevention and Control (ECDC). Now-casting and short-term forecasting during influenza pandemics. A focused developmental ECDC workshop. Meeting Report. Stockholm: ECDC; 29-30 November 2007. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0711_MER_Forecasting_during_Influenza_ Pandemics.pdf
85. Centers for Disease Control and Prevention (CDC). Updated CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009 - April 10, 2010. Atlanta: CDC; 14 May 2009. Available from: http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm
86. Molbak K. Estimating the mortality and Years of Potental Life Lost attributable to influenza to direct public health action. 2010 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE); 11-13 Nov 2010; Lisbon, Portugal.
87. World Health Organization Regional Office for Europe (WHO/ Europe). Guidance for influenza surveillance in humans. Copenhagen WHO/Europe; May 2011. Available from: http:// www.euro.who.int/document/e92738.pdf
88. Amato-Gauci A, Zucs P, Snacken R, Ciancio B, Lopez V, Broberg E, et al. Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe. Euro Surveill. 2011;16(26):pii=19903. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19903
89. European Center for Disease Prevention and Control (ECDC). Number of fatal cases. Stockholm: ECDC; 3 May 2010. Available from: http://ecdc.europa.eu/en/healthtopics/H1N1/epidemiological_data/Pages/number_confirmed_fatal_2009_pandemic_influenza_cases.aspx
90. Health Protection Agency (HPA). Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave. London: HPA; 2 Dec 2009. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave
91. van Gageldonk-Lafeber AB, Hooiveld M, Meijer A, Donker GA, Veldman-Ariesen M-J, van der Hoek W, et al. The relative clinical impact of 2009 pandemic influenza A (H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5-14 year olds. Influenza Other Respi Viruses. 2011;5(6):e513-e520.
92. Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A. Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April- September 2009. Euro Surveill. 2010;15(49):pii=19740. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19740
93. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med. 2011;8(7):e1001053.
94. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15(20):pii=19571. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19571
95. Nguyen-Van-Tam J, Openshaw PJM, Hashim A, Gadd EM, Lim WS, Semple MG, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax. 2010;65(7):645-61.
96. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M, UKOSS. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;342:d3214.
97. Broberg E, Nicoll A, Amato-Gauci A. Seroprevalence to A(H1N1)2009 virus - where are we? Clin Vaccine Immunol. 2011;18(8):1205-12.
98. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2010;85(24):229-225.
99. European Center for Disease Prevention and Control (ECDC). Pandemic (H1N1) 2009 influenza. ECDC Interim risk assessment. Stockholm: ECDC; 21 Aug 2009. Available from: http://ecdc.europa.eu/en/healthtopics/H1N1/Documents/1001_RA_090821.pdf
100. Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos JC, dos Santos T, et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med. 2010;7(6):e1000275.
101. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med. 2009;361(2):112-115
102. Laurie KL, Huston P, Riley S, Katz JM, Willison DJ, Tam JS et al. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respi Viruses. Forthcoming. DOI: 10.1111/j.1750-2659.2012.0370b.x.
103. World Health Organization Regional Office for Europe (WHO/Europe), European Center for Disease Prevention and Control (ECDC). Meeting on influenza surveillance. Ljubljana, Slovenia, 7-9 June 2011. Summary report. Copenhagen: WHO/Europe; 2011. Available from: http://www.euro.who.int/__data/assets/pdf_file/0007/155509/e96072.pdf